Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Net Cash Flow (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Net Cash Flow for 2 consecutive years, with $449000.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 102.5% to $449000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$40.3 million through Dec 2025, down 50.15% year-over-year, with the annual reading at -$40.3 million for FY2025, 50.15% down from the prior year.
  • Net Cash Flow hit $449000.0 in Q4 2025 for Connect Biopharma Holdings, up from -$2.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $8.7 million in Q1 2024 to a low of -$30.6 million in Q1 2025.